chr6-83170370-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_015599.3(PGM3):c.1474C>T(p.Arg492*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000279 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015599.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251408Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135880
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461822Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 20AN XY: 727218
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
Immunodeficiency 23 Pathogenic:3
- -
The p.Arg520X variant in PGM3 has not been previously reported in individuals wi th immunodeficiency, but has been identified in 4/66736 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs 144104577). This nonsense variant leads to a premature termination codon at posi tion 520, which is predicted to lead to a truncated or absent protein. Bialleli c variants in the PGM3 gene that result in reduced PGM3 expression and/or enzyma tic function are reported to cause autosomal recessive immunodeficiency 23 (MIM: 615816). In summary, although additional studies are required to fully establi sh its clinical significance, the p.Arg520X variant is likely pathogenic. -
This sequence change creates a premature translational stop signal (p.Arg520*) in the PGM3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PGM3 are known to be pathogenic (PMID: 17548465, 24589341, 24931394). This variant is present in population databases (rs144104577, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with PGM3-congenital disorder of glycosylation (PMID: 35040011). ClinVar contains an entry for this variant (Variation ID: 505650). For these reasons, this variant has been classified as Pathogenic. -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: PGM3 c.1558C>T (p.Arg520X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2.8e-05 in 251408 control chromosomes (gnomAD). c.1558C>T has been reported in the literature in at least one compound heterozygous individual affected with Severe Combined Immunodeficiency (Winslow_2022). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: one classified the variant as likely pathogenic and two as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35040011) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at